Abstract

Literature data indicate a significant immunoregulatory role of melatonin. Melatonin exerts an effect directly affecting leucocytes bearing specific melatonin receptors or indirectly by means of melatonin regulating other hormones, opioids or cytokines. Despite numerous experiments, the influence of the hormone on the immune system is still controversial. Melatonin affects the immune response acting as both an activator and an inhibitor of the inflammatory process. The hormone acts as an “immunological buffer” activating impaired immunity in immunosuppression, chronic stress or old age as well as suppressing overreaction of the immune system. Melatonin mediates between neurohormonal and immune systems by means of the immune-pineal axis acting as a negative feedback mechanism. The axis connects development of the immune reaction with pineal activity and melatonin secretion induced by inflammatory mediators. The seasonal and circadian fluctuation of the melatonin level and the fluctuation related changes of the immune parameters can be responsible for some autoimmune and infectious diseases. In spite of that, there is a growing number of papers suggesting considerable therapeutic potential of melatonin in inflammatory disease treatment. This paper presents well-systematized information on the mechanism of melatonin action and its influence on cells involved in the inflammatory process – neutrophils and monocytes.

References

• 1. Alamili M., Bendtzen K., Lykkesfeldt J., Rosenberg J., Gögenur I.:Melatonin suppresses markers of inflammation and oxidative damagein a human daytime endotoxemia model. J. Crit. Care, 2014; 29:184.e9-184.e13
  Google Scholar
• 2. Albertini M.C., Radogna F., Accorsi A., Uguccioni F., PaternosterL., Cerella C., De Nicola M., D’Alessio M., Bergamaschi A., Magrini A.,Ghibelli L.: Intracellular pro-oxidant activity of melatonin deprivesU937 cells of reduced glutathione without affecting glutathione peroxidaseactivity. Ann. N. Y. Acad. Sci., 2006; 1091: 10-16
  Google Scholar
• 3. Bagchi M., Balmoori J., Ye X., Bagchi D., Ray S.D., Stohs S.J.: Protectiveeffect of melatonin on naphthalene-induced oxidative stressand DNA damage in cultured macrophage J774A.1 cells. Mol. Cell.Biochem., 2001; 221: 49-55
  Google Scholar
• 4. Barjavel M.J., Mamdouh Z., Raghbate N., Bakouche O.: Differentialexpression of the melatonin receptor in human monocytes. J.Immunol., 1998; 160: 1191-1197
  Google Scholar
• 5. Blask D.E., Sauer L.A., Dauchy R.T.: Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanismsof action and their implications for circadian-based cancer therapy.Curr. Top. Med. Chem., 2002; 2: 113-132
  Google Scholar
• 6. Calvo J.R., Reiter R.J., García J.J., Ortiz G.G., Tan D.X., KarbownikM.: Characterization of the protective effects of melatonin and relatedindoles against alpha-naphthylisothiocyanate-induced liverinjury in rats. J. Cell. Biochem., 2001; 80: 461-470
  Google Scholar
• 7. Carrillo-Vico A., Guerrero J.M., Lardone P.J., Reiter R.J.: A reviewof the multiple actions of melatonin on the immune system. Endocrine,2005; 27: 189-200
  Google Scholar
• 8. Carrillo-Vico A., Lardone P.J., Alvarez-Sánchez N., Rodríguez-RodríguezA., Guerrero J.M.: Melatonin: buffering the immune system.Int. J. Mol. Sci., 2013; 14: 8638-8683
  Google Scholar
• 9. Carrillo-Vico A., Lardone P.J., Naji L., Fernández-Santos J.M., Martín-LacaveI., Guerrero J.M., Calvo J.R.: Beneficial pleiotropic actionsof melatonin in an experimental model of septic shock in mice:regulation of pro-/anti-inflammatory cytokine network, protectionagainst oxidative damage and anti-apoptotic effects. J. PinealRes., 2005; 39: 400-408
  Google Scholar
• 10. Choi E.Y., Jin J.Y., Lee J.Y., Choi J.I., Choi I.S., Kim S.J.: Melatonininhibits Prevotella intermedia lipopolysaccharide-induced productionof nitric oxide and interleukin-6 in murine macrophages by suppressingNF-κB and STAT1 activity. J. Pineal Res., 2011; 50: 197-206
  Google Scholar
• 11. Couto-Moraes R., Palermo-Neto J., Markus R.P.: The immunepinealaxis: stress as a modulator of pineal gland function. Ann. N.Y. Acad. Sci., 2009; 1153: 193-202
  Google Scholar
• 12. Cutando A., López-Valverde A., Arias-Santiago S., De Vicente J.,De Diego R.G.: Role of melatonin in cancer treatment. AnticancerRes., 2012; 32: 2747-2753
  Google Scholar
• 13. Cutolo M., Villaggio B., Candido F., Valenti S., Giusti M., Felli L.,Sulli A., Accardo S.: Melatonin influences interleukin-12 and nitricoxide production by primary cultures of rheumatoid synovial macrophagesand THP-1 cells. Ann. N. Y. Acad. Sci., 1999; 876: 246-254
  Google Scholar
• 14. Cuzzocrea S., Zingarelli B., Costantino G., Caputi A.P.: Protectiveeffect of melatonin in a non-septic shock model induced by zymosanin the rat. J. Pineal Res., 1998; 25: 24-33
  Google Scholar
• 15. Dowell S.F.: Seasonal variation in host susceptibility and cyclesof certain infectious diseases. Emerg. Infect. Dis., 2001; 7: 369-374
  Google Scholar
• 16. Espino J., Bejarano I., Paredes S.D., Barriga C., Rodríguez A.B.,Pariente J.A.: Protective effect of melatonin against human leukocyteapoptosis induced by intracellular calcium overload: relation withits antioxidant actions. J. Pineal Res., 2011; 51: 195-206
  Google Scholar
• 17. Espino J., Pariente J.A., Rodríguez A.B.: Oxidative stress and immunosenescence:therapeutic effects of melatonin. Oxid. Med. Cell.Longev., 2012; 2012: 670294
  Google Scholar
• 18. Ferry G., Ubeaud C., Lambert P.H., Bertin S., Cogé F., ChomaratP., Delagrange P., Serkiz B., Bouchet J.P., Truscott R.J., BoutinJ.A.: Molecular evidence that melatonin is enzymatically oxidizedin a different manner than tryptophan: investigations with bothindoleamine 2,3-dioxygenase and myeloperoxidase. Biochem. J.,2005; 388: 205-215
  Google Scholar
• 19. Fischer T.W., Scholz G., Knöll B., Hipler U.C., Elsner P.: Melatoninreduces UV-induced reactive oxygen species in a dose-dependentmanner in IL-3-stimulated leukocytes. J. Pineal Res., 2001; 31: 39-45
  Google Scholar
• 20. Fjaerli O., Lund T., Osterud B.: The effect of melatonin on cellularactivation processes in human blood. J. Pineal Res., 1999; 26: 50-55
  Google Scholar
• 21. Franca E., Junior A., de Oliveira S., Honório-Franca A.: Chronoimmunomodulationof melatonin on bactericidal activity of humanblood phagocytes. Internet J. Microbiol., 2008; 6: 1-7
  Google Scholar
• 22. Galijasevic S., Abdulhamid I., Abu-Soud H.M.: Melatonin is a potentinhibitor for myeloperoxidase. Biochemistry, 2008; 47: 2668-2677
  Google Scholar
• 23. García-Mauriño S., Gonzalez-Haba M.G., Calvo J.R., Rafii-El-IdrissiM., Sanchez-Margalet V., Goberna R., Guerrero J.M.: Melatoninenhances IL-2, IL-6, and IFN-gamma production by human circulatingCD4+ cells: a possible nuclear receptor-mediated mechanisminvolving T helper type 1 lymphocytes and monocytes. J. Immunol.,1997; 159: 574-581
  Google Scholar
• 24. García-Mauriño S., Pozo D., Carrillo-Vico A., Calvo J.R., GuerreroJ.M.: Melatonin activates Th1 lymphocytes by increasing IL-12production. Life Sci., 1999; 65: 2143-2150
  Google Scholar
• 25. Gilad E., Cuzzocrea S., Zingarelli B., Salzman A.L., Szabó C.: Melatoninis a scavenger of peroxynitrite. Life Sci., 1997; 60: PL169-PL174
  Google Scholar
• 26. Gilad E., Wong H.R., Zingarelli B., Virág L., O’Connor M., SalzmanA.L., Szabó C.: Melatonin inhibits expression of the inducible isoformof nitric oxide synthase in murine macrophages: role of inhibitionof NFκB activation. FASEB J., 1998; 12: 685-693
  Google Scholar
• 27. Giordano M., Vermeulen M., Palermo M.S.: Seasonal variationsin antibody-dependent cellular cytotoxicity regulation by melatonin.FASEB J., 1993; 7: 1052-1054
  Google Scholar
• 28. Gitto E., Karbownik M., Reiter R.J., Tan D.X., Cuzzocrea S., ChiurazziP., Cordaro S., Corona G., Trimarchi G., Barberi I.: Effects of melatonintreatment in septic newborns. Pediatr. Res., 2001; 50: 756-760
  Google Scholar
• 29. Haldar C., Singh S.S., Rai S., Skwarło-Sońta K., Pawlak J.,Singaravel M.: Melatonin and Immunomodulation: Involvementof the Neuroendocrine Network. W: Experimental Endocrinologyand Reproductive Biology, red.: Haldar C., Singaravel M.,Pandi-Perumal S.R., Cardinali D.P., Science Publisher, Enfield,USA 2008, 297-314
  Google Scholar
• 30. Hriscu M.L.: Modulatory factors of circadian phagocytic activity.Ann. N.Y. Acad. Sci., 2005; 1057: 403-430
  Google Scholar
• 31. Huang S.H., Cao X.J., Wei W.: Melatonin decreases TLR3-mediatedinflammatory factor expression via inhibition of NF-κB activationin respiratory syncytial virus-infected RAW264.7 macrophages. J.Pineal Res., 2008; 45: 93-100
  Google Scholar
• 32. Jaworek J., Szklarczyk J., Jaworek A.K., Nawrot-Porąbka K., Leja–Szpak A., Bonior J., Kot M.: Protective effect of melatonin on acutepancreatitis. Int. J. Inflam., 2012; 2012: 173675
  Google Scholar
• 33. Karasek M.: Melatonin, human aging, and age-related diseases.Exp. Gerontol., 2004; 39: 1723-1729
  Google Scholar
• 34. Karasek M.: Znaczenie kliniczne melatoniny. Post. Nauk Med.,2007; 10: 395-398
  Google Scholar
• 35. Karasek M., Winczyk K.: Melatonin in humans. J. Physiol. Pharmacol.,2006; 57 (Suppl. 5): 19-39
  Google Scholar
• 36. Katila H., Cantell K., Appelberg B., Rimón R.: Is there a seasonalvariation in the interferon-producing capacity of healthy subjects?J. Interferon Res., 1993; 13: 233-234
  Google Scholar
• 37. Klink M., Bednarska K., Blus E., Kiełbik M., Sułowska Z.: Seasonalchanges in activities of human neutrophils in vitro. Inflamm.Res., 2012; 61: 11-16
  Google Scholar
• 38. Kornacka A., Schroeder G., Eitner K., Szczapa J., Puchalska M.:Wpływ melatoniny na procesy antyoksydacyjne u noworodkówz sepsą – wyniki wstępne. Pediatr. Pol., 2012; 87: 262-267
  Google Scholar
• 39. Kuci S., Becker J., Veit G., Handgretinger R., Attanasio A.,Bruchelt G., Treuner J., Niethammer D., Gupta D.: Circadian variationsin the immunomodulatory role of the pineal gland. Neuroendocrinol.Lett., 1988; 10: 65-79
  Google Scholar
• 40. Li X.J., Zhang L.M., Gu J., Zhang A.Z., Sun F.Y.: Melatonin decreasesproduction of hydroxyl radical during cerebral ischemiareperfusion.Acta Pharmacol. Sin., 1997; 18: 394-396
  Google Scholar
• 41. Lopez-Gonzalez M.A., Calvo J.R., Segura J.J., Guerrero J.M.: Characterizationof melatonin binding sites in human peripheral bloodneutrophils. Biotechnol. Ther., 1993; 4: 253-262
  Google Scholar
• 42. Lotufo C.M., Lopes C., Dubocovich M.L., Farsky S.H., Markus R.P.:Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesionto rat microcirculation. Eur. J. Pharmacol., 2001; 430: 351-357
  Google Scholar
• 43. Lotufo C.M., Yamashita C.E., Farsky S.H., Markus R.P.: Melatonineffect on endothelial cells reduces vascular permeability increaseinduced by leukotriene B4. Eur. J. Pharmacol., 2006; 534: 258-263
  Google Scholar
• 44. Maes M., Stevens W., Scharpé S., Bosmans E., De Meyer F.,D’Hondt P., Peeters D., Thompson P., Cosyns P., De Clerck L., BridtsC., Neels H., Wauters A., Cooreman W.: Seasonal variation in peripheralblood leukocyte subsets and in serum interleukin-6, and solubleinterleukin -2 and -6 receptor concentrations in normal volunteers.Experientia, 1994; 50: 821-829
  Google Scholar
• 45. Maestroni G.J., Conti A., Lissoni P.: Colony-stimulating activityand hematopoietic rescue from cancer chemotherapy compoundsare induced by melatonin via endogenous interleukin 4. CancerRes., 1994; 54: 4740-4743
  Google Scholar
• 46. Maldonado M.D., Mora-Santos M., Naji L., Carrascosa-SalmoralM.P., Naranjo M.C., Calvo J.R.: Evidence of melatonin synthesis andrelease by mast cells. Possible modulatory role on inflammation.Pharmacol. Res., 2010; 62: 282-287
  Google Scholar
• 47. Marcola M., da Silveira Cruz-Machado S., Fernandes P.A., MonteiroA.W., Markus R.P., Tamura E.K.: Endothelial cell adhesiveness isa function of environmental lighting and melatonin level. J. PinealRes., 2013; 54: 162-169
  Google Scholar
• 48. Markus R.P., Cecon E., Pires-Lapa M.A.: Immune-pineal axis:nuclear factor κB (NF-κB) mediates the shift in the melatonin sourcefrom pinealocytes to immune competent cells. Int. J. Mol. Sci., 2013;14: 10979-10997
  Google Scholar
• 49. Markus R.P., Ferreira Z.S., Fernandes P.A., Cecon E.: The immunepinealaxis: a shuttle between endocrine and paracrine melatoninsources. Neuroimmunomodulation, 2007; 14: 126-133
  Google Scholar
• 50. Mayo J.C., Sainz R.M., Tan D.X., Hardeland R., Leon J., RodriguezC., Reiter R.J.: Anti-inflammatory actions of melatonin and its metabolites,N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) andN1-acetyl-5-methoxykynuramine (AMK), in macrophages. J. Neuroimmunol.,2005; 165: 139-149
  Google Scholar
• 51. Mayo J.C., Tan D.X., Sainz R.M., Lopez-Burillo S., Reiter R.J.: Oxidativedamage to catalase induced by peroxyl radicals: functionalprotection by melatonin and other antioxidants. Free Radic. Res.,2003; 37: 543-553
  Google Scholar
• 52. Melamud L., Golan D., Luboshitzky R., Lavi I., Miller A.: Melatonindysregulation, sleep disturbances and fatigue in multiple sclerosis.J. Neurol. Sci., 2012; 314: 37-40
  Google Scholar
• 53. Melchart D., Martin P., Hallek M., Holzmann M., Jurcic X., WagnerH.: Circadian variation of the phagocytic activity of polymorphonuclearleukocytes and of various other parameters in 13 healthymale adults. Chronobiol. Int., 1992; 9: 35-45
  Google Scholar
• 54. Morrey K.M., McLachlan J.A., Serkin C.D., Bakouche O.: Activationof human monocytes by the pineal hormone melatonin. J. Immunol.,1994; 153: 2671-2680
  Google Scholar
• 55. Noda Y., Mori A., Liburdy R., Packer L.: Melatonin and its precursorsscavenge nitric oxide. J. Pineal Res., 1999; 27: 159-163
  Google Scholar
• 56. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J., Cardinali D.P.,Poeggeler B., Hardeland R.: Melatonin: Nature’s most versatile biologicalsignal? FEBS J., 2006; 273: 2813-2838
  Google Scholar
• 57. Pandi-Perumal S.R., Trakht I., Srinivasan V., Spence D.W., MaestroniG.J., Zisapel N., Cardinali D.P.: Physiological effects of melatonin:role of melatonin receptors and signal transduction pathways.Prog. Neurobiol., 2008; 85: 335-353
  Google Scholar
• 58. Peña C., Rincon J., Pedreanez A., Viera N., Mosquera J.: Chemotacticeffect of melatonin on leukocytes. J. Pineal Res., 2007; 43: 263-269
  Google Scholar
• 59. Pieri C., Recchioni R., Moroni F., Marcheselli F., Marra M., Marinoni S., Di Primio R.: Melatonin regulates the respiratory burst ofhuman neutrophils and their depolarization. J. Pineal Res., 1998;24: 43-49
  Google Scholar
• 60. Pontes G.N., Cardoso E.C., Carneiro-Sampaio M.M., Markus R.P.:Pineal melatonin and the innate immune response: the TNF-α increaseafter cesarean section suppresses nocturnal melatonin production.J. Pineal Res., 2007; 43: 365-371
  Google Scholar
• 61. Popławski P., Derlacz R.A.: Jak działa melatonina. Postępy Biochem.,2003; 49: 9-17
  Google Scholar
• 62. Pozo D., Garcia-Maurino S., Guerrero J.M., Calvo J.R.: mRNAexpression of nuclear receptor RZR/RORα, melatonin membranereceptor MT1, and hydroxindole-O-methyltransferase in differentpopulations of human immune cells. J. Pineal Res., 2004; 37: 48-54
  Google Scholar
• 63. Radogna F., Diederich M., Ghibelli L.: Melatonin: A pleiotropicmolecule regulating inflammation. Biochem. Pharmacol., 2010; 80:1844-1852
  Google Scholar
• 64. Radogna F., Paternoster L., De Nicola M., Cerella C., AmmendolaS., Bedini A., Tarzia G., Aquilano K., Ciriolo M., Ghibelli L.: Rapid andtransient stimulation of intracellular reactive oxygen species bymelatonin in normal and tumor leukocytes. Toxicol. Appl. Pharmacol.,2009; 239: 37-45
  Google Scholar
• 65. Radogna F., Sestili P., Martinelli C., Paolillo M., Paternoster L.,Albertini M.C., Accorsi A., Gualandi G., Ghibelli L.: Lipoxygenasemediatedpro-radical effect of melatonin via stimulation of arachidonicacid metabolism. Toxicol. Appl. Pharmacol., 2009; 238: 170-177
  Google Scholar
• 66. Recchioni R., Marcheselli F., Moroni F., Gáspár R., DamjanovichS., Pieri C.: Melatonin increases the intensity of respiratory burstand prevents L-selectin shedding in human neutrophils in vitro. Biochem.Biophys. Res. Commun., 1998; 252: 20-24
  Google Scholar
• 67. Reiter R.J.: The melatonin rhythm: both a clock and a calendar.Experientia, 1993; 49: 654-664
  Google Scholar
• 68. Shin I.S., Shin N.R., Park J.W., Jeon C.M., Hong J.M., Kwon O.K.,Kim J.S., Lee I.C., Kim J.C., Oh S.R., Ahn K.S.: Melatonin attenuatesneutrophil inflammation and mucus secretion in cigarette smokeinducedchronic obstructive pulmonary diseases via the suppressionof Erk-Sp1 signaling. J. Pineal Res., 2015; 58: 50-60
  Google Scholar
• 69. Silva S.O., Carvalho S.R., Ximenes V.F., Okada S.S., Campa A.:Melatonin and its kynurenin-like oxidation products affect the microbicidalactivity of neutrophils. Microbes Infect., 2006; 8: 420-425
  Google Scholar
• 70. Silva S.O., Rodrigues M.R., Carvalho S.R., Catalani L.H., CampaA., Ximenes V.F.: Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine,by activated leukocytes. J. Pineal Res., 2004; 37:171-175
  Google Scholar
• 71. Silva S.O., Rodrigues M.R., Ximenes V.F., Bueno-da-Silva A.E.,Amarante-Mendes G.P., Campa A.: Neutrophils as a specific targetfor melatonin and kynuramines: effects on cytokine release. J. Neuroimmunol.,2004; 156: 146-152
  Google Scholar
• 72. Srinivasan V., Spence D.W., Trakht I., Pandi-Perumal S.R., CardinaliD.P., Maestroni G.J.: Immunomodulation by melatonin: itssignificance for seasonally occurring diseases. Neuroimmunomodulation,2008; 15: 93-101
  Google Scholar
• 73. Sulli A., Maestroni G.J., Villaggio B., Hertens E., Craviotto C.,Pizzorni C., Briata M., Seriolo B., Cutolo M.: Melatonin serum levelsin rheumatoid arthritis. Ann. N. Y. Acad. Sci., 2002; 966: 276-283
  Google Scholar
• 74. Tahan G., Gramignoli R., Marongiu F., Aktolga S., Cetinkaya A.,Tahan V., Dorko K.: Melatonin expresses powerful anti-inflammatoryand antioxidant activities resulting in complete improvementof acetic-acid-induced colitis in rats. Dig. Dis. Sci., 2011; 56: 715-720
  Google Scholar
• 75. Tamura E.K., Fernandes P.A., Marçola M., da Silveira Cruz-MachadoS., Markus R.P.: Long-lasting priming of endothelial cells byplasma melatonin levels. PLoS One, 2010; 5: e13958
  Google Scholar
• 76. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J.:Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr.J., 1993; 1: 57-60
  Google Scholar
• 77. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., Reiter R.J.:One molecule, many derivatives: a never-ending interaction of melatoninwith reactive oxygen and nitrogen species? J. Pineal Res.,2007; 42: 28-42
  Google Scholar
• 78. Tan D.X., Reiter R.J., Manchester L.C., Yan M.T., El-Sawi M., SainzR.M., Mayo J.C., Kohen R., Allegra M., Hardeland R.: Chemical andphysical properties and potential mechanisms: melatonin as a broadspectrum antioxidant and free radical scavenger. Curr. Top. Med.Chem., 2002; 2: 181-197
  Google Scholar
• 79. Veneroso C., Tuñón M.J., González-Gallego J., Collado P.S.: Melatoninreduces cardiac inflammatory injury induced by acute exercise.J. Pineal Res., 2009; 47: 184-191
  Google Scholar
• 80. Wu J.Y., Tsou M.Y., Chen T.H., Chen S.J., Tsao C.M., Wu C.C.:Therapeutic effects of melatonin on peritonitis-induced septic shockwith multiple organ dysfunction syndrome in rats. J. Pineal Res.,2008; 45: 106-116
  Google Scholar
• 81. Wu W.S., Chou M.T., Chao C.M., Chang C.K., Lin M.T., Chang C.P.:Melatonin reduces acute lung inflammation, edema, and hemorrhagein heatstroke rats. Acta Pharmacol. Sin., 2012; 33: 775-782
  Google Scholar
• 82. Xia M.Z., Liang Y.L., Wang H., Chen X., Huang Y.Y., Zhang Z.H.,Chen Y.H., Zhang C., Zhao M., Xu D.X., Song L.H.: Melatonin modulatesTLR4-mediated inflammatory genes through MyD88- and TRIF-dependentsignaling pathways in lipopolysaccharide-stimulatedRAW264.7 cells. J. Pineal Res., 2012; 53: 325-334
  Google Scholar
• 83. Zawilska J., Nowak J.: Rytmika okołodobowa i zegar biologiczny.Sen, 2002; 2: 127-136
  Google Scholar
• 84. Zawilska J.B., Skene D.J., Arendt J.: Physiology and pharmacologyof melatonin in relation to biological rhythms. Pharmacol. Rep.,2009; 61: 383-410
  Google Scholar
• 85. Zhang H., Squadrito G.L., Pryor W.A.: The reaction of melatoninwith peroxynitrite: formation of melatonin radical cation andabsence of stable nitrated products. Biochem. Biophys. Res. Commun.,1998; 251: 83-87
  Google Scholar
• 86. Zhong L.Y., Yang Z.H., Li X.R., Wang H., Li L.: Protective effectsof melatonin against the damages of neuroendocrine-immune inducedby lipopolysaccharide in diabetic rats. Exp. Clin. Endocrinol.Diabetes, 2009; 117: 463-469
  Google Scholar

Full text